Related references
Note: Only part of the references are listed.The effects of trifluoperazine on brain edema, aquaporin-4 expression and metabolic markers during the acute phase of stroke using photothrombotic mouse model
Nicole J. Sylvain et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2021)
The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Click Chemistry in Proteomic Investigations
Christopher G. Parker et al.
CELL (2020)
Microfluidic synthesis of fatty acid esters: Integration of dynamic combinatorial chemistry and scale effect
Wei He et al.
CHEMICAL ENGINEERING JOURNAL (2020)
The impact of chemoinformatics on drug discovery in the pharmaceutical industry
Karina Martinez-Mayorga et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018
Olivier J. Wouters et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
T cells make a home in the degenerating brain
Michael T. Heneka
NATURE (2020)
Salivary Redox Biomarkers in Selected Neurodegenerative Diseases
Mateusz Maciejczyk et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Biomaterials and Culture Systems for Development of Organoid and Organ-on-a-Chip Models
Katya D'Costa et al.
ANNALS OF BIOMEDICAL ENGINEERING (2020)
Targeting Aquaporin-4 Subcellular Localization to Treat Central Nervous System Edema
Philip Kitchen et al.
CELL (2020)
Lab-on-a-Chip Systems for Aptamer-Based Biosensing
Niazul Khan et al.
MICROMACHINES (2020)
Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery
Shi-Dong Chen et al.
EXPERT OPINION ON DRUG DISCOVERY (2020)
T cells in Alzheimer's disease: space invaders
Roisin M. McManus et al.
LANCET NEUROLOGY (2020)
Complete aggregation pathway of amyloid beta (1-40) and (1-42) resolved on an atomically clean interface
Peter Niraj Nirmalraj et al.
SCIENCE ADVANCES (2020)
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020
Leoni Rolfes et al.
BIODRUGS (2020)
Modelling neurodegenerative diseases with3Dbrain organoids
Yujung Chang et al.
BIOLOGICAL REVIEWS (2020)
Design and Validation of a Human Brain Endothelial Microvessel-on-a-Chip Open Microfluidic Model Enabling Advanced Optical Imaging
Mootaz M. Salman et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Recent Advances in Biosensors Based Nanostructure for Pharmaceutical Analysis
Eslam Pourbasheer et al.
CURRENT ANALYTICAL CHEMISTRY (2019)
Translational in vitro research: integrating 3D drug discovery and development processes into the drug development pipeline
Jens M. Kelm et al.
DRUG DISCOVERY TODAY (2019)
Inhibitors of Mammalian Aquaporin Water Channels
Mohammed Abir-Awan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Advances in Microfluidic Blood-Brain Barrier (BBB) Models
Arianna Oddo et al.
TRENDS IN BIOTECHNOLOGY (2019)
The energetic brain - A review from students to students
Melina Paula Bordone et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Compact Grating-Coupled Biosensor for the Analysis of Thrombin
Dania Kotlarek et al.
ACS SENSORS (2019)
Brain-on-a-chip: A history of development and future perspective
Seokyoung Bang et al.
BIOMICROFLUIDICS (2019)
A human-on-a-chip approach to tackling rare diseases
Camilly P. Pires de Mello et al.
DRUG DISCOVERY TODAY (2019)
Molecular pathology of neurodegenerative diseases: principles and practice
Gabor G. Kovacs
JOURNAL OF CLINICAL PATHOLOGY (2019)
Advancing Drug Discovery via Artificial Intelligence
H. C. Stephen Chan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
A Point of Inflection and Reflection on Systems Chemical Biology
Eachan O. Johnson et al.
ACS CHEMICAL BIOLOGY (2019)
Blockade of α4 integrins reduces leukocyte-endothelial interactions in cerebral vessels and improves memory in a mouse model of Alzheimer's disease
Enrica Pietronigro et al.
SCIENTIFIC REPORTS (2019)
Conditional Overexpression of rtn4al in Muscle of Adult Zebrafish Displays Defects Similar to Human Amyotrophic Lateral Sclerosis
Cheng-Yung Lin et al.
MARINE BIOTECHNOLOGY (2019)
Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration
Anna M. Speicher et al.
MOLECULAR NEURODEGENERATION (2019)
Functional morphology of the blood-brain barrier in health and disease
Stefan Liebner et al.
ACTA NEUROPATHOLOGICA (2018)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design
Sheikh Arslan Sehgal et al.
CURRENT NEUROPHARMACOLOGY (2018)
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
Nicholas Ekow Thomford et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Computer-calculated compounds
Nic Fleming
NATURE (2018)
Recent Advances in Electrochemical Biosensors Based on Enzyme Inhibition for Clinical and Pharmaceutical Applications
Loubna El Harrad et al.
SENSORS (2018)
Modeling Parkinson's Disease in C. elegans
Jason F. Cooper et al.
JOURNAL OF PARKINSONS DISEASE (2018)
Zebrafish models: do we have valid paradigms for depression?
Murilo S. de Abreu et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2018)
Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning
Sigrid A. Langhans
FRONTIERS IN PHARMACOLOGY (2018)
Drug metabolism in drug discovery and development
Zhoupeng Zhang et al.
ACTA PHARMACEUTICA SINICA B (2018)
Glia-neuron energy metabolism in health and diseases: New insights into the role of nervous system metabolic transporters
Mithilesh Kumar Jha et al.
EXPERIMENTAL NEUROLOGY (2018)
Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent
Koki Fujimori et al.
NATURE MEDICINE (2018)
Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases
Claudio Soto et al.
NATURE NEUROSCIENCE (2018)
Microglia innately develop within cerebral organoids
Paul R. Ormel et al.
NATURE COMMUNICATIONS (2018)
Efficient Parameter Estimation Enables the Prediction of Drug Response Using a Mechanistic Pan-Cancer Pathway Model
Fabian Froehlich et al.
CELL SYSTEMS (2018)
Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features
Matthew P. Shaw et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
Neurodegenerative Diseases: Regenerative Mechanisms and Novel Therapeutic Approaches
Rashad Hussain et al.
BRAIN SCIENCES (2018)
A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport
Nienke R. Wevers et al.
FLUIDS AND BARRIERS OF THE CNS (2018)
Harnessing the Versatility of Optical Biosensors for Target-Based Small-Molecule Drug Discovery
Tim Kaminski et al.
ACS SENSORS (2017)
Hypothermia increases aquaporin 4 (AQP4) plasma membrane abundance in human primary cortical astrocytes via a calcium/transient receptor potential vanilloid 4 (TRPV4)- and calmodulin-mediated mechanism
Mootaz M. Salman et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2017)
Perspectives on optical biosensor utility in small-molecule screening
Tim Kaminski et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015
Dev Mehta et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
A review on protein misfolding, aggregation and strategies to prevent related ailments
Tooba Naz Shamsi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)
Why do so many clinical trials of therapies for Alzheimer's disease fail?
Roy M. Anderson et al.
LANCET (2017)
CRISPR/Cas9 Editing of the Mutant Huntingtin Allele In Vitro and In Vivo
Alex Mas Monteys et al.
MOLECULAR THERAPY (2017)
T cells from patients with Parkinson's disease recognize α-synuclein peptides
David Sulzer et al.
NATURE (2017)
Opportunities and challenges in phenotypic drug discovery: an industry perspective
John G. Moffat et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
The use of brain organoids to investigate neural development and disease
Elizabeth Di Lullo et al.
NATURE REVIEWS NEUROSCIENCE (2017)
The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes
Valentin K. Gribkoff et al.
NEUROPHARMACOLOGY (2017)
Rapid characterization of the CHO platform cell line and identification of pseudo attP sites for PhiC31 integrase
Narges Damavandi et al.
PROTEIN EXPRESSION AND PURIFICATION (2017)
Trends in high-throughput and functional neuroimaging in Caenorhabditis elegans
Yongmin Cho et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2017)
C. elegans as Model for Drug Discovery
Maria Carretero et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2017)
Fluorescence- and bioluminescence-based approaches to study GPCR ligand binding
Leigh A. Stoddart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases
Kelly M. Haston et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 (2016)
Microfluidic technology enhances the potential of human pluripotent stem cells
Onelia Gagliano et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Sydney Brenner on the Genetics of Caenorhabditis elegans
Bob Goldstein
GENETICS (2016)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Cell-Based Assay Design for High-Content Screening of Drug Candidates
Gregory Nierode et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2016)
Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models
Stephen J. Haggarty et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2016)
ZNStress: a high-throughput drug screening protocol for identification of compounds modulating neuronal stress in the transgenic mutant sod1G93R zebrafish model of amyotrophic lateral sclerosis
Alexander McGown et al.
MOLECULAR NEURODEGENERATION (2016)
Accelerated cellular on- and off-target screening of bioactive compounds using microarrays
Jiaqi Fu et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2016)
Unified 2D and 3D cell-based high-throughput screening platform using a micropillar/microwell chip
Dong Woo Lee et al.
SENSORS AND ACTUATORS B-CHEMICAL (2016)
The evolution of drug discovery: from phenotypes to targets, and back
Hassan Al-Ali
MEDCHEMCOMM (2016)
Large-scale microfluidics providing high-resolution and high-throughput screening of Caenorhabditis elegans poly-glutamine aggregation model
Sudip Mondal et al.
NATURE COMMUNICATIONS (2016)
Sydney Brenner on the Genetics of Caenorhabditis elegans
Bob Goldstein
GENETICS (2016)
High-Throughput Toxicity and Phenotypic Screening of 3D Human Neural Progenitor Cell Cultures on a Microarray Chip Platform
Gregory J. Nierode et al.
STEM CELL REPORTS (2016)
Three Dimensional Human Neuro-Spheroid Model of Alzheimer's Disease Based on Differentiated Induced Pluripotent Stem Cells
Han-Kyu Lee et al.
PLOS ONE (2016)
INaP selective inhibition reverts precocious inter- and motorneurons hyperexcitability in the Sod1-G93R zebrafish ALS model
Lorena Benedetti et al.
SCIENTIFIC REPORTS (2016)
Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss
Rahasson R. Ager et al.
HIPPOCAMPUS (2015)
Identification and Molecular Mechanisms of the Rapid Tonicity-induced Relocalization of the Aquaporin 4 Channel
Philip Kitchen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Three-dimensional brain-on-a-chip with an interstitial level of flow and its application as an in vitro model of Alzheimer's disease
JiSoo Park et al.
LAB ON A CHIP (2015)
CRISPR/Cas9: a powerful genetic engineering tool for establishing large animal models of neurodegenerative diseases
Zhuchi Tu et al.
MOLECULAR NEURODEGENERATION (2015)
Using C. elegans for aging research
Heidi A. Tissenbaum
INVERTEBRATE REPRODUCTION & DEVELOPMENT (2015)
Microfluidically supported biochip design for culture of endothelial cell layers with improved perfusion conditions
Martin Raasch et al.
BIOFABRICATION (2015)
A 3D Alzheimer's disease culture model and the induction of P21-activated kinase mediated sensing in iPSC derived neurons
Dawei Zhang et al.
BIOMATERIALS (2014)
Animal models of dementia and cognitive dysfunction
Neha et al.
LIFE SCIENCES (2014)
Microfluidic organs-on-chips
Sangeeta N. Bhatia et al.
NATURE BIOTECHNOLOGY (2014)
Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model
Sung Hoon Baik et al.
NEUROBIOLOGY OF AGING (2014)
Zebrafish as an emerging model for studying complex brain disorders
Allan V. Kalueff et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Alzheimer's disease drug-development pipeline: few candidates, frequent failures
Jeffrey L. Cummings et al.
ALZHEIMERS RESEARCH & THERAPY (2014)
Worming forward: amyotrophic lateral sclerosis toxicity mechanisms and genetic interactions in Caenorhabditis elegans
Martine Therrien et al.
FRONTIERS IN GENETICS (2014)
Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases
Adanna G. Alexander et al.
FRONTIERS IN GENETICS (2014)
Analysis of Protein Aggregation in Neurodegenerative Disease
Jeppe T. Pedersen et al.
ANALYTICAL CHEMISTRY (2013)
Early interneuron dysfunction in ALS: Insights from a mutant sod1 zebrafish model
Alexander McGown et al.
ANNALS OF NEUROLOGY (2013)
Glial Influence on the Blood Brain Barrier
Jorge Ivan Alvarez et al.
GLIA (2013)
Systematic Reviews of Animal Models: Methodology versus Epistemology
Ray Greek et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
TDP-43 high throughput screening analyses in neurodegeneration: Advantages and pitfalls
Emanuele Buratti et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Microfluidic Chemotaxis Platform for Differentiating the Roles of Soluble and Bound Amyloid-β on Microglial Accumulation
Hansang Cho et al.
SCIENTIFIC REPORTS (2013)
Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease
Keith A. Vossel et al.
JAMA NEUROLOGY (2013)
The economic cost of brain disorders in Europe
J. Olesen et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Ligand-receptor interaction platforms and their applications for drug discovery
Ye Fang
EXPERT OPINION ON DRUG DISCOVERY (2012)
Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis
Kazuaki Kanai et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
Susan Duty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Animal models in the drug discovery pipeline for Alzheimer's disease
Debby Van Dam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis
Abraham Acevedo-Arozena et al.
DISEASE MODELS & MECHANISMS (2011)
The full cost and burden of disorders of the brain in Europe exposed for the first time
David J. Nutt
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Cost of disorders of the brain in Europe 2010
Anders Gustavsson et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2011)
Design and Implementation of High Throughput Screening Assays
Ricardo Macarron et al.
MOLECULAR BIOTECHNOLOGY (2011)
Cell death assays for drug discovery
Oliver Kepp et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Impact of high-throughput screening in biomedical research
Ricardo Macarron et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Transgenic zebrafish models of neurodegenerative diseases
Jonathan J. Sager et al.
BRAIN STRUCTURE & FUNCTION (2010)
Ligand binding assays at equilibrium: validation and interpretation
Edward C. Hulme et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Tau-directed drug discovery for Alzheimer's disease and related tauopathies: A focus on tau assembly inhibitors
Kurt R. Brunden et al.
EXPERIMENTAL NEUROLOGY (2010)
Parkinson's disease: insights from pathways
Mark R. Cookson et al.
HUMAN MOLECULAR GENETICS (2010)
Current status on Alzheimer disease molecular genetics: from past, to present, to future
Karolien Bettens et al.
HUMAN MOLECULAR GENETICS (2010)
A microfluidic device for a pharmacokinetic-pharmacodynamic (PK-PD) model on a chip
Jong Hwan Sung et al.
LAB ON A CHIP (2010)
Structure and function of the blood-brain barrier
N. Joan Abbott et al.
NEUROBIOLOGY OF DISEASE (2010)
Automated High-Content Live Animal Drug Screening Using C-elegans Expressing the Aggregation Prone Serpin α1-antitrypsin Z
Sager J. Gosai et al.
PLOS ONE (2010)
High-content screening of primary neurons: ready for prime time
Aaron Daub et al.
CURRENT OPINION IN NEUROBIOLOGY (2009)
Why animal studies are often poor predictors of human reactions to exposure
Michael B. Bracken
JOURNAL OF THE ROYAL SOCIETY OF MEDICINE (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
A Robotic Platform for Quantitative High-Throughput Screening
Sam Michael et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2008)
No death without life: vital functions of apoptotic effectors
L. Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2008)
High throughput screening for neurodegeneration and complex disease phenotypes
Hemant Varma et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2008)
Strategies to advance translational research into brain barriers
Edward Neuwelt et al.
LANCET NEUROLOGY (2008)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors
Kazutoshi Takahashi et al.
CELL (2007)
Origin and evolution of high throughput screening
D. A. Pereira et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Drosophila melanogaster neurobiology, neuropharmacology, and how the fly can inform central nervous system drug discovery
Charles D. Nichols
PHARMACOLOGY & THERAPEUTICS (2006)
A network dysfunction perspective on neurodegenerative diseases
Jorge J. Palop et al.
NATURE (2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors
Kazutoshi Takahashi et al.
CELL (2006)
Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage
K Kanai et al.
BRAIN (2006)
Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease
C Cunningham et al.
JOURNAL OF VIROLOGY (2005)
A flexible data analysis tool for chemical genetic screens
BP Kelley et al.
CHEMISTRY & BIOLOGY (2004)
Highly sensitive fluorescence detection technology currently available for HTS
C Eggeling et al.
DRUG DISCOVERY TODAY (2003)
The price of innovation: new estimates of drug development costs
JA DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2003)
Advantages and disadvantages of Caenorhabditis elegans for aging research
TE Johnson
EXPERIMENTAL GERONTOLOGY (2003)
Drug-like properties and the causes of poor solubility and poor permeability
CA Lipinski
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2000)
Strategies for discovering drugs from previously unexplored natural products
A Harvey
DRUG DISCOVERY TODAY (2000)
Share Paper
